(3beta)-Abieta-8,11,13-triene-3,12-diol(CAS: 564-73-8)

This compound is subject to various regulatory guidelines. It must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazard communication. Under REACH regulations, manufacturers and importers need to classify and register the substance if it meets the tonnage threshold. In the USA, it is regulated by the EPA and FDA for environmental and safety standards, respectively.

There are several alternatives to (3beta)-Abieta-8,11,13-triene-3,12-diol in synthesis, such as using related tricyclic diterpenes. Common substitute reagents include 13-oxo-abieta-8,11-dien-3-one and related isomers. These alternatives can offer similar functionality while potentially improving synthesis efficiency or reducing cost.

The market for (3beta)-Abieta-8,11,13-triene-3,12-diol is driven by its applications in pharmaceuticals and cosmetics. Recent research trends focus on its potential as a bioactive compound in drug discovery. Market demand and research interest are expected to grow due to its unique chemical structure and biological activity.

Waste containing (3beta)-Abieta-8,11,13-triene-3,12-diol should be collected in appropriate containers and stored under controlled conditions. Incineration or professional waste disposal services should be used for disposal to ensure environmental protection. Follow local regulations and guidelines for hazardous waste management to prevent contamination and ensure safety.